Loading clinical trials...
Loading clinical trials...
A Single Center, Open-label, Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin in Healthy Subjects
Conditions
Interventions
Simvastatin
Rosuvastatin
+1 more
Locations
1
United States
Celerion
Tempe, Arizona, United States
Start Date
September 1, 2015
Primary Completion Date
October 1, 2015
Completion Date
October 1, 2015
Last Updated
September 2, 2022
NCT06290258
NCT00090662
NCT07310264
NCT06716502
NCT07483606
NCT06342713
Lead Sponsor
Madrigal Pharmaceuticals, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions